Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease

Authors

  • Ratan Das Gupta Professor and Head, Department of Nephrology, Shaheed Suhrawardy Medical College, Dhaka.
  • Mesbah Uddin Noman Associate Professor, Nephrology. OSD,DGHS,Mohakhali, Dhaka

Keywords:

ET polypeptide, FDA

Abstract

Abstract not available

J Shaheed Suhrawardy Med Coll 2022; 14(2): 58-62

Abstract
272
PDF
376

Downloads

Published

2024-05-14

How to Cite

Gupta, R. D. ., & Noman, M. U. . (2024). Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease. Journal of Shaheed Suhrawardy Medical College, 14(2), 58-62. https://doi.org/10.3329/jssmc.v14i2.73180

Issue

Vol. 14 No. 2 (2022)

Section

Review Articles

License

Copyright ©2015 Shaheed Suhrawardy Medical College Teachers’ Association.

How to Cite

Gupta, R. D. ., & Noman, M. U. . (2024). Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease. Journal of Shaheed Suhrawardy Medical College, 14(2), 58-62. https://doi.org/10.3329/jssmc.v14i2.73180